Jane Street’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Sell
21,400
-8,000
-27% -$66.4K ﹤0.01% 9555
2026
Q1
$246K Buy
29,400
+11,100
+61% +$117K ﹤0.01% 9662
2025
Q4
$264K Sell
18,300
-18,200
-50% -$227K ﹤0.01% 9123
2025
Q3
$352K Buy
36,500
+7,300
+25% +$64.6K ﹤0.01% 8601
2025
Q2
$240K Buy
+29,200
New +$244K ﹤0.01% 8240
2024
Q2
Sell
-18,300
Closed -$386K 10055
2024
Q1
$386K Buy
+18,300
New +$326K ﹤0.01% 7146
2023
Q3
Sell
-15,100
Closed -$302K 9256
2023
Q2
$302K Buy
+15,100
New +$291K ﹤0.01% 7112
2023
Q1
Sell
-33,000
Closed -$748K 9773
2022
Q4
$748K Sell
33,000
-1,000
-3% -$22.6K ﹤0.01% 5467
2022
Q3
$899K Buy
34,000
+400
+1% +$11.9K ﹤0.01% 5598
2022
Q2
$830K Buy
33,600
+26,300
+360% +$657K ﹤0.01% 5826
2022
Q1
$242K Sell
7,300
-16,100
-69% -$447K ﹤0.01% 8742
2021
Q4
$765K Sell
23,400
-6,800
-23% -$232K ﹤0.01% 6447
2021
Q3
$1.27M Buy
30,200
+10,300
+52% +$371K ﹤0.01% 5436
2021
Q2
$773K Buy
+19,900
New +$712K ﹤0.01% 6386
2021
Q1
Sell
-6,500
Closed -$295K 9504
2020
Q4
$295K Sell
6,500
-25,500
-80% -$891K ﹤0.01% 6445
2020
Q3
$881K Buy
32,000
+25,500
+392% +$831K ﹤0.01% 4304
2020
Q2
$239K Buy
+6,500
New +$242K ﹤0.01% 6155

Other funds holding RGNX

Jane Street's RGNX Position: Q2 2026 in Review

Jane Street increased its Regenxbio (RGNX) stake by 140% in Q2 2026, buying an estimated $1.23M and bringing the position to 253,493 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #4490.

Jane Street first reported a position in RGNX in Q3 2017 and has held it in 25 quarters since. The position peaked at $3.92M in Q4 2020. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Jane Street held 253,493 shares of Regenxbio worth $3.04M as of Q2 2026.
  • Jane Street bought 147,945 Regenxbio shares in Q2 2026, an estimated $1.23M.
  • Regenxbio made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4490 holding.
  • Jane Street first reported a position in Regenxbio in Q3 2017 and has held it in 25 quarters since.
  • Jane Street's Regenxbio position peaked at $3.92M in Q4 2020.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.